Some estimates (dependent on progress):
Current figures:
MC: $172mil / SP: $2.02
2025 H1: FDA approval for EMU
MC: $500mil to $1bil / SP: $5.88 - 11.76
2025 H2: First sales agreements for EMU + studies complete for portable device +/- FDA approval for portable device
MC: $2-3bil / SP: $23.53 - 35.29
2026 beyond: Acceleration of EMU sales + initial sales for portable device
MC: $5-10bil / SP: $58.82 - 117.65
*does not account for any dilution that may occur, but unlikely to be notable following Keysight investment, and already have pilot production plant ready
*reasonable expectation based on PME and COH comparisons
It will never be possible to have an "apples for apples" comparison, but EMV has a much larger adressable market compared to PME and COH.
Open to dissection: too unrealistic, or too conservative?
(20min delay)